Elekta

A leader in precision radiation therapy, we are committed to ensuring every patient with cancer has access to the best care possible.

[Elekta @Elekta]

Leksell Gamma Knife Lightning can generate complex, high-quality treatment plans in under a minute. This rapid planning capability allows clinicians to respond to same-day changes and deliver personalized care with speed and accuracy adapting to daily changes. #GammaKnife #Radiosurgery #SRS

[American Association of Physicists in Medicine @aapmHQ]

Real clinics are cutting toxicity in HALF with Adaptive RT & @Elekta 's Paul Barry & Brett Sloman will show you how. Unity Linac. Elekta ONE Planning. Real outcomes. Practical strategies. Q&A included. Mon. July 20 · 12:15 PM · Lunch session #AAPMCOMP2026 #AdaptiveRT #RadOnc

[Elekta @Elekta]

#AAPMCOMP2026 is almost here! From adaptive radiotherapy and imaging innovations to workflow optimization and QA, we’re excited to connect with everyone at booth #1131 in Vancouver. What's the topic you're most looking forward to discussing this year? #AAPM2026 #MedicalPhysics

[Elekta @Elekta]

🎙️ We recently came together with RadChat to spotlight RTT perspectives through a live conversation shaped by shared experiences and audience interaction. The podcast episode is now available. Tune in! 🔗 https://t.co/PmoqCXdud3

[Elekta @Elekta]

Did you know? In 2025, the majority of all published intracranial #radiosurgery research focused on Leksell Gamma Knife.

The #GammaKnife continues to set the benchmark for intracranial radiosurgery and while other systems contribute to the field, none match the depth of evidence, precision and long-term clinical experience. #SRS

Learn more 👉 https://t.co/QSuxsmK4qc

[Elekta @Elekta]

Congratulations to the team behind the Leksell Vantage X-Ray Fiducial Box on its @reddot Design Award! Designed for precise stereotactic image registration, it pairs accuracy with clinician-centered design. A great example of innovation helping advance treatment planning and care delivery. #RedDotAward #reddotmoment #ProductDesign #SRS

[Elekta @Elekta]

If you could improve one thing instantly, what would it be?

[Elekta @Elekta]

Thanks to everyone who joined us for Elekta’s Capital Markets Day yesterday in Stockholm.

Together with our CEO Jakob Just-Bomholt, CFO Klara Eiritz, and parts of the leadership team, we shared how we are planning to strengthen profitability and drive long-term growth in the coming years through focused innovation and improved execution.

Watch the webcast and see the presentation here: https://t.co/WTCcWAoxns

[Elekta @Elekta]

Today we announced Elekta’s new mid-term financial targets and a more detailed outlook for FY 2026/27 ahead of our Capital Markets Day in Stockholm.

👉 Read more in the press release: https://t.co/6AT15rOPrE

[Elekta @Elekta]

As adaptive radiotherapy continues to move into routine clinical practice, Health Canada’s clearance of Elekta Evo with Iris and the Online Adaptive solution marks another important step in that transition.

Ardie Ermers, Head of Region Americas, says:

“This milestone supports the ongoing shift toward making adaptive radiotherapy part of routine care in Canada. It enables clinicians to personalize treatment in real time and improve precision in cancer care. Canada plays an important role in advancing innovation, and this approval also supports collaboration across the oncology community, particularly as we look ahead to AAPM | COMP Joint Scientific Meeting in Vancouver, where adaptive radiotherapy will be a key focus."

[Elekta @Elekta]

What motivates you most in your role?

[Elekta @Elekta]

Join us for Elekta’s Capital Markets Day on Wednesday, June 17, where CEO Jakob Just-Bomholt, CFO Klara Eiritz, and members of our leadership team will share insights into our strategy and future direction.

Register to attend: https://t.co/X1cKVhCrqf

[Elekta @Elekta]

Today, we present our Q4 & full year results. It's a strong finish to the year with improved profitability and our strongest cash flow in five years (SEK 1,392 M). With our new operating model in place, we’re focused on near-term profitability and mid-term innovation driven growth. More to come at our Capital Markets Day on June 17. 👉 Read more: https://t.co/COflBtmkQ7

[Elekta @Elekta]

Attending #ISRS2026 in Sydney? Join our Lunch Symposium to explore how innovations in stereotactic radiotherapy are expanding treatment possibilities, including new indications, alternative fractionation approaches, and improved workflow efficiency. Save your spot 👉 https://t.co/RIth8GPOkE

[Elekta @Elekta]

Highlights from #ESTRO26! ☕️
If you missed our Coffee & Connect sessions at the booth, here are a few key insights and perspectives shared by Prof. Dr Chian Gani, Dr. Matthias Lampe, Dr. Hui Khee Looe and Dr. Erwin Wiegman – covering innovation, clinical experience and the future of radiotherapy.

[Elekta @Elekta]

New findings in glioblastoma show how MR‑guided adaptive radiotherapy can reduce treatment volumes by 40% while maintaining outcomes and a 4% marginal failure vs 11% historically. A step forward in delivering precise care and helping protect healthy brain tissue.
👉 Read the full study in The Lancet Oncology: https://t.co/L9rF1TSGxV

*Study by Detsky et al., UNITED trial investigators at Sunnybrook Health Sciences Centre.

[Elekta @Elekta]

A heartfelt thank you to everyone, both near and far, who spent time with us at #ESTRO26. We are grateful for the opportunity to connect in person and look forward to seeing you next year in Milan, Italy!

[Elekta @Elekta]

Which topic has been your key focus at #ESTRO26?

[Elekta @Elekta]

Emerging evidence presented at #ESTRO26 highlights advances in MR-guided adaptive radiotherapy across multiple cancer indications. Read more in today’s press release ➡️ https://t.co/dKV6VUeJb2